Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

June 29, 2022
In this webinar, Dr. Isabel Quiros Gonzalez, Head of the Histopathology Core at the University of Oviedo and previously with Cancer Research UK Cambridge Institute, outlines her work using MSOT (multispectral optoacoustic tomography) to assess response to a vascular-disruptive treatment in a preclinical breast cancer model.
YouTube

By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

Contact us

If you have any questions about our technology, applications or products, don’t hesitate to get in touch.